25 XP   0   0   10

Hofseth Biocare ASA
Buy, Hold or Sell?

Let's analyse Hofseth Biocare ASA together

PenkeI guess you are interested in Hofseth Biocare ASA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hofseth Biocare ASA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hofseth Biocare ASA

I send you an email if I find something interesting about Hofseth Biocare ASA.

Quick analysis of Hofseth Biocare ASA (30 sec.)










What can you expect buying and holding a share of Hofseth Biocare ASA? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.24
Expected worth in 1 year
kr0.01
How sure are you?
28.6%

+ What do you gain per year?

Total Gains per Share
kr-0.23
Return On Investment
-11.5%

For what price can you sell your share?

Current Price per Share
kr2.03
Expected price per share
kr2 - kr2.23
How sure are you?
50%

1. Valuation of Hofseth Biocare ASA (5 min.)




Live pricePrice per Share (EOD)

kr2.03

Intrinsic Value Per Share

kr1.92 - kr2.39

Total Value Per Share

kr2.16 - kr2.63

2. Growth of Hofseth Biocare ASA (5 min.)




Is Hofseth Biocare ASA growing?

Current yearPrevious yearGrowGrow %
How rich?$8.5m$11.5m-$872.1k-8.2%

How much money is Hofseth Biocare ASA making?

Current yearPrevious yearGrowGrow %
Making money-$2m-$3.1m$1m48.6%
Net Profit Margin-59.1%-123.0%--

How much money comes from the company's main activities?

3. Financial Health of Hofseth Biocare ASA (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#634 / 1007

Most Revenue
#289 / 1007

Most Profit
#603 / 1007

Most Efficient
#567 / 1007

What can you expect buying and holding a share of Hofseth Biocare ASA? (5 min.)

Welcome investor! Hofseth Biocare ASA's management wants to use your money to grow the business. In return you get a share of Hofseth Biocare ASA.

What can you expect buying and holding a share of Hofseth Biocare ASA?

First you should know what it really means to hold a share of Hofseth Biocare ASA. And how you can make/lose money.

Speculation

The Price per Share of Hofseth Biocare ASA is kr2.03. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hofseth Biocare ASA.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hofseth Biocare ASA, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.24. Based on the TTM, the Book Value Change Per Share is kr-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hofseth Biocare ASA.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.01-0.3%0.00-0.1%-0.01-0.4%-0.01-0.3%0.00-0.2%
Usd Book Value Change Per Share-0.01-0.3%-0.01-0.3%0.000.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-0.3%-0.01-0.3%0.000.0%0.000.0%0.000.0%
Usd Price Per Share0.25-0.26-0.42-0.51-0.41-
Price to Earnings Ratio-12.31-17.19--13.53--15.89--13.64-
Price-to-Total Gains Ratio-49.44-36.93--43.51--16.29--17.54-
Price to Book Ratio11.80-9.61-15.85-18.45-9.05-
Price-to-Total Gains Ratio-49.44-36.93--43.51--16.29--17.54-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1827
Number of shares5473
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (5473 shares)-28.64-0.93
Gains per Year (5473 shares)-114.57-3.72
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-115-1250-4-14
20-229-2400-7-18
30-344-3550-11-22
40-458-4700-15-26
50-573-5850-19-30
60-687-7000-22-34
70-802-8150-26-38
80-917-9300-30-42
90-1031-10450-34-46
100-1146-11600-37-50

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%2.010.00.016.7%2.018.00.010.0%3.025.00.010.7%3.025.00.010.7%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%8.020.00.028.6%8.020.00.028.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.028.00.0%0.00.028.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%5.015.00.025.0%8.020.00.028.6%8.020.00.028.6%

Fundamentals of Hofseth Biocare ASA

About Hofseth Biocare ASA

Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol, joint, eye, brain, and cardiovascular function; ProGo, a salmon protein hydrolysate powder for treatment of irondeficiency anaemia, irritable bowel syndrome, and sarcopenia; CalGo, a marine calcium powder produced to support cartilage function, joint health, and bone strength; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2009 and is headquartered in Ålesund, Norway.

Fundamental data was last updated by Penke on 2024-04-22 03:30:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hofseth Biocare ASA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hofseth Biocare ASA earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • A Net Profit Margin of -45.5% means that kr-0.46 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hofseth Biocare ASA:

  • The MRQ is -45.5%. The company is making a huge loss. -2
  • The TTM is -59.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-45.5%TTM-59.1%+13.6%
TTM-59.1%YOY-123.0%+63.9%
TTM-59.1%5Y-140.4%+81.3%
5Y-140.4%10Y-157.1%+16.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.5%-207.2%+161.7%
TTM-59.1%-218.5%+159.4%
YOY-123.0%-282.4%+159.4%
5Y-140.4%-432.2%+291.8%
10Y-157.1%-593.8%+436.7%
1.1.2. Return on Assets

Shows how efficient Hofseth Biocare ASA is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • -5.7% Return on Assets means that Hofseth Biocare ASA generated kr-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hofseth Biocare ASA:

  • The MRQ is -5.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.7%TTM-5.8%+0.2%
TTM-5.8%YOY-8.5%+2.7%
TTM-5.8%5Y-7.7%+1.9%
5Y-7.7%10Y-7.8%+0.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.7%-13.2%+7.5%
TTM-5.8%-12.6%+6.8%
YOY-8.5%-11.5%+3.0%
5Y-7.7%-13.7%+6.0%
10Y-7.8%-15.5%+7.7%
1.1.3. Return on Equity

Shows how efficient Hofseth Biocare ASA is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • -24.0% Return on Equity means Hofseth Biocare ASA generated kr-0.24 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hofseth Biocare ASA:

  • The MRQ is -24.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -19.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.0%TTM-19.5%-4.4%
TTM-19.5%YOY-28.9%+9.3%
TTM-19.5%5Y-23.0%+3.4%
5Y-23.0%10Y-25.7%+2.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.0%-16.7%-7.3%
TTM-19.5%-15.8%-3.7%
YOY-28.9%-14.4%-14.5%
5Y-23.0%-19.0%-4.0%
10Y-25.7%-19.9%-5.8%

1.2. Operating Efficiency of Hofseth Biocare ASA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hofseth Biocare ASA is operating .

  • Measures how much profit Hofseth Biocare ASA makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hofseth Biocare ASA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-23.5%+23.5%
TTM-23.5%YOY-113.1%+89.6%
TTM-23.5%5Y-110.5%+87.0%
5Y-110.5%10Y-134.2%+23.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.5%+286.5%
TTM-23.5%-229.1%+205.6%
YOY-113.1%-288.4%+175.3%
5Y-110.5%-480.7%+370.2%
10Y-134.2%-624.7%+490.5%
1.2.2. Operating Ratio

Measures how efficient Hofseth Biocare ASA is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.20 means that the operating costs are kr2.20 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Hofseth Biocare ASA:

  • The MRQ is 2.203. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.264. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.203TTM2.264-0.061
TTM2.264YOY2.885-0.621
TTM2.2645Y3.048-0.784
5Y3.04810Y3.261-0.212
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2033.231-1.028
TTM2.2643.307-1.043
YOY2.8853.774-0.889
5Y3.0485.667-2.619
10Y3.2617.558-4.297

1.3. Liquidity of Hofseth Biocare ASA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hofseth Biocare ASA is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.67 means the company has kr0.67 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Hofseth Biocare ASA:

  • The MRQ is 0.670. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.823. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.670TTM0.823-0.153
TTM0.823YOY1.056-0.233
TTM0.8235Y1.375-0.552
5Y1.37510Y1.259+0.116
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6703.890-3.220
TTM0.8234.182-3.359
YOY1.0565.343-4.287
5Y1.3756.135-4.760
10Y1.2596.453-5.194
1.3.2. Quick Ratio

Measures if Hofseth Biocare ASA is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • A Quick Ratio of 0.15 means the company can pay off kr0.15 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hofseth Biocare ASA:

  • The MRQ is 0.154. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.200. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.154TTM0.200-0.046
TTM0.200YOY0.338-0.138
TTM0.2005Y0.404-0.204
5Y0.40410Y0.321+0.083
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1543.528-3.374
TTM0.2004.059-3.859
YOY0.3385.390-5.052
5Y0.4046.138-5.734
10Y0.3216.488-6.167

1.4. Solvency of Hofseth Biocare ASA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hofseth Biocare ASA assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hofseth Biocare ASA to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.76 means that Hofseth Biocare ASA assets are financed with 76.4% credit (debt) and the remaining percentage (100% - 76.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hofseth Biocare ASA:

  • The MRQ is 0.764. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.707. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.764TTM0.707+0.057
TTM0.707YOY0.686+0.021
TTM0.7075Y0.640+0.067
5Y0.64010Y0.658-0.018
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7640.339+0.425
TTM0.7070.337+0.370
YOY0.6860.273+0.413
5Y0.6400.368+0.272
10Y0.6580.391+0.267
1.4.2. Debt to Equity Ratio

Measures if Hofseth Biocare ASA is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • A Debt to Equity ratio of 324.3% means that company has kr3.24 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hofseth Biocare ASA:

  • The MRQ is 3.243. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.490. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ3.243TTM2.490+0.753
TTM2.490YOY2.427+0.063
TTM2.4905Y2.018+0.472
5Y2.01810Y2.153-0.135
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2430.388+2.855
TTM2.4900.403+2.087
YOY2.4270.342+2.085
5Y2.0180.432+1.586
10Y2.1530.461+1.692

2. Market Valuation of Hofseth Biocare ASA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Hofseth Biocare ASA generates.

  • Above 15 is considered overpriced but always compare Hofseth Biocare ASA to the Biotechnology industry mean.
  • A PE ratio of -12.31 means the investor is paying kr-12.31 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hofseth Biocare ASA:

  • The EOD is -8.827. Based on the earnings, the company is expensive. -2
  • The MRQ is -12.306. Based on the earnings, the company is expensive. -2
  • The TTM is 17.191. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD-8.827MRQ-12.306+3.479
MRQ-12.306TTM17.191-29.497
TTM17.191YOY-13.533+30.724
TTM17.1915Y-15.890+33.081
5Y-15.89010Y-13.642-2.248
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.827-2.249-6.578
MRQ-12.306-2.553-9.753
TTM17.191-2.669+19.860
YOY-13.533-4.107-9.426
5Y-15.890-6.247-9.643
10Y-13.642-6.499-7.143
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hofseth Biocare ASA:

  • The EOD is 68.083. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The MRQ is 94.913. Based on how much money comes from the company's main activities, the company is overpriced. -1
  • The TTM is 173.939. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD68.083MRQ94.913-26.831
MRQ94.913TTM173.939-79.026
TTM173.939YOY-19.320+193.259
TTM173.9395Y13.647+160.292
5Y13.64710Y5.901+7.745
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD68.083-2.858+70.941
MRQ94.913-3.288+98.201
TTM173.939-3.552+177.491
YOY-19.320-5.560-13.760
5Y13.647-8.326+21.973
10Y5.901-8.881+14.782
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hofseth Biocare ASA is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 11.80 means the investor is paying kr11.80 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Hofseth Biocare ASA:

  • The EOD is 8.465. Based on the equity, the company is overpriced. -1
  • The MRQ is 11.801. Based on the equity, the company is expensive. -2
  • The TTM is 9.614. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD8.465MRQ11.801-3.336
MRQ11.801TTM9.614+2.187
TTM9.614YOY15.847-6.233
TTM9.6145Y18.450-8.836
5Y18.45010Y9.047+9.403
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD8.4651.929+6.536
MRQ11.8012.090+9.711
TTM9.6142.091+7.523
YOY15.8472.881+12.966
5Y18.4503.545+14.905
10Y9.0473.936+5.111
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hofseth Biocare ASA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.057-0.058+2%0.007-970%-0.002-97%0.009-768%
Book Value Per Share--0.2400.300-20%0.325-26%0.335-28%0.276-13%
Current Ratio--0.6700.823-19%1.056-37%1.375-51%1.259-47%
Debt To Asset Ratio--0.7640.707+8%0.686+11%0.640+19%0.658+16%
Debt To Equity Ratio--3.2432.490+30%2.427+34%2.018+61%2.153+51%
Dividend Per Share----0%-0%-0%-0%
Eps---0.057-0.031-46%-0.086+50%-0.062+8%-0.054-7%
Free Cash Flow Per Share--0.0070.027-73%-0.084+1227%-0.039+626%-0.040+633%
Free Cash Flow To Equity Per Share---0.0350.005-866%-0.025-30%-0.002-95%-0.006-84%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--2.389--------
Intrinsic Value_10Y_min--1.924--------
Intrinsic Value_1Y_max---0.104--------
Intrinsic Value_1Y_min---0.102--------
Intrinsic Value_3Y_max---0.050--------
Intrinsic Value_3Y_min---0.053--------
Intrinsic Value_5Y_max--0.318--------
Intrinsic Value_5Y_min--0.273--------
Market Cap802004280.000-39%1118079314.9001121042422.6250%1856857200.000-40%2239886236.525-50%1813753625.375-38%
Net Profit Margin---0.455-0.591+30%-1.230+170%-1.404+208%-1.571+245%
Operating Margin----0.2350%-1.1310%-1.1050%-1.3420%
Operating Ratio--2.2032.264-3%2.885-24%3.048-28%3.261-32%
Pb Ratio8.465-39%11.8019.614+23%15.847-26%18.450-36%9.047+30%
Pe Ratio-8.827+28%-12.30617.191-172%-13.533+10%-15.890+29%-13.642+11%
Price Per Share2.030-39%2.8302.8380%4.700-40%5.670-50%4.591-38%
Price To Free Cash Flow Ratio68.083-39%94.913173.939-45%-19.320+120%13.647+595%5.901+1508%
Price To Total Gains Ratio-35.462+28%-49.43836.930-234%-43.513-12%-16.293-67%-17.535-65%
Quick Ratio--0.1540.200-23%0.338-54%0.404-62%0.321-52%
Return On Assets---0.057-0.058+3%-0.085+51%-0.077+36%-0.078+39%
Return On Equity---0.240-0.195-18%-0.289+20%-0.230-4%-0.257+7%
Total Gains Per Share---0.057-0.058+2%0.007-970%-0.002-97%0.009-768%
Usd Book Value--8526870.00010668465.000-20%11540655.000-26%11898175.500-28%9799241.786-13%
Usd Book Value Change Per Share---0.005-0.005+2%0.001-970%0.000-97%0.001-768%
Usd Book Value Per Share--0.0220.027-20%0.029-26%0.030-28%0.025-13%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.005-0.003-46%-0.008+50%-0.006+8%-0.005-7%
Usd Free Cash Flow--265050.000967500.000-73%-2988315.000+1227%-1394559.000+626%-1412183.571+633%
Usd Free Cash Flow Per Share--0.0010.002-73%-0.008+1227%-0.004+626%-0.004+633%
Usd Free Cash Flow To Equity Per Share---0.0030.000-866%-0.002-30%0.000-95%-0.001-84%
Usd Market Cap72180385.200-39%100627138.341100893818.0360%167117148.000-40%201589761.287-50%163237826.284-38%
Usd Price Per Share0.183-39%0.2550.2550%0.423-40%0.510-50%0.413-38%
Usd Profit---2044350.000-2093872.500+2%-3111862.500+52%-2409255.000+18%-2050386.429+0%
Usd Revenue--4489740.0004605615.000-3%2540677.500+77%2387943.000+88%2243928.214+100%
Usd Total Gains Per Share---0.005-0.005+2%0.001-970%0.000-97%0.001-768%
 EOD+4 -4MRQTTM+11 -21YOY+13 -195Y+12 -2010Y+10 -22

3.2. Fundamental Score

Let's check the fundamental score of Hofseth Biocare ASA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.827
Price to Book Ratio (EOD)Between0-18.465
Net Profit Margin (MRQ)Greater than0-0.455
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.154
Current Ratio (MRQ)Greater than10.670
Debt to Asset Ratio (MRQ)Less than10.764
Debt to Equity Ratio (MRQ)Less than13.243
Return on Equity (MRQ)Greater than0.15-0.240
Return on Assets (MRQ)Greater than0.05-0.057
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Hofseth Biocare ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.217
Ma 20Greater thanMa 502.120
Ma 50Greater thanMa 1002.211
Ma 100Greater thanMa 2002.399
OpenGreater thanClose2.020
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in NOK. All numbers in thousands.

Summary
Total Assets401,982
Total Liabilities307,239
Total Stockholder Equity94,743
 As reported
Total Liabilities 307,239
Total Stockholder Equity+ 94,743
Total Assets = 401,982

Assets

Total Assets401,982
Total Current Assets147,374
Long-term Assets254,609
Total Current Assets
Cash And Cash Equivalents 17,669
Net Receivables 16,285
Inventory 101,565
Other Current Assets 11,855
Total Current Assets  (as reported)147,374
Total Current Assets  (calculated)147,374
+/-0
Long-term Assets
Property Plant Equipment 156,656
Intangible Assets 56,428
Long-term Assets  (as reported)254,609
Long-term Assets  (calculated)213,084
+/- 41,525

Liabilities & Shareholders' Equity

Total Current Liabilities220,045
Long-term Liabilities87,880
Total Stockholder Equity94,743
Total Current Liabilities
Accounts payable 201,145
Other Current Liabilities 7,280
Total Current Liabilities  (as reported)220,045
Total Current Liabilities  (calculated)208,425
+/- 11,620
Long-term Liabilities
Long term Debt Total 87,881
Long-term Liabilities Other -1
Long-term Liabilities  (as reported)87,880
Long-term Liabilities  (calculated)87,880
+/-0
Total Stockholder Equity
Common Stock3,951
Retained Earnings 90,793
Other Stockholders Equity -1
Total Stockholder Equity (as reported)94,743
Total Stockholder Equity (calculated)94,743
+/-0
Other
Capital Stock3,951
Cash And Equivalents17,669
Cash and Short Term Investments 17,669
Common Stock Shares Outstanding 395,081
Liabilities and Stockholders Equity 401,982
Net Invested Capital 94,744
Net Working Capital -72,671
Property Plant and Equipment Gross 156,656



Balance Sheet

Currency in NOK. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
159,353
183,045
142,661
150,790
184,239
151,709
151,209
196,064
187,945
245,098
228,896
330,540
293,012
293,669
306,872
293,288
459,134
443,339
458,119
443,342
415,973
397,917
378,873
421,334
411,030
391,269
410,959
401,982
401,982410,959391,269411,030421,334378,873397,917415,973443,342458,119443,339459,134293,288306,872293,669293,012330,540228,896245,098187,945196,064151,209151,709184,239150,790142,661183,045159,353
   > Total Current Assets 
37,481
92,681
53,924
63,692
94,891
63,183
55,328
103,223
100,318
91,850
81,423
176,160
137,853
139,560
141,899
106,801
271,470
250,343
228,240
198,130
170,311
154,918
139,562
183,311
175,754
158,463
156,693
147,374
147,374156,693158,463175,754183,311139,562154,918170,311198,130228,240250,343271,470106,801141,899139,560137,853176,16081,42391,850100,318103,22355,32863,18394,89163,69253,92492,68137,481
       Cash And Cash Equivalents 
16,165
64,398
18,162
29,778
42,068
23,792
10,514
58,047
48,641
36,517
19,868
109,362
93,211
67,446
60,997
23,769
170,712
138,535
112,573
85,506
47,211
30,572
5,688
46,215
29,881
22,853
16,724
17,669
17,66916,72422,85329,88146,2155,68830,57247,21185,506112,573138,535170,71223,76960,99767,44693,211109,36219,86836,51748,64158,04710,51423,79242,06829,77818,16264,39816,165
       Net Receivables 
4,366
6,622
5,145
4,702
33,265
6,499
11,146
5,308
17,661
12,480
8,490
6,682
5,561
13,087
14,733
7,285
21,083
16,957
17,765
11,218
23,458
18,639
18,112
14,294
14,072
15,867
18,379
16,285
16,28518,37915,86714,07214,29418,11218,63923,45811,21817,76516,95721,0837,28514,73313,0875,5616,6828,49012,48017,6615,30811,1466,49933,2654,7025,1456,6224,366
       Inventory 
15,589
19,690
27,074
19,772
16,858
20,579
23,753
24,405
29,402
35,849
42,478
31,987
33,986
45,655
54,883
64,479
73,302
85,285
87,238
88,976
90,813
92,714
101,899
108,927
116,525
108,752
110,133
101,565
101,565110,133108,752116,525108,927101,89992,71490,81388,97687,23885,28573,30264,47954,88345,65533,98631,98742,47835,84929,40224,40523,75320,57916,85819,77227,07419,69015,589
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
153,248
147,473
154,380
155,160
154,109
164,973
186,487
187,664
192,996
229,879
245,212
245,662
243,000
239,310
238,023
235,282
232,806
254,266
254,609
254,609254,266232,806235,282238,023239,310243,000245,662245,212229,879192,996187,664186,487164,973154,109155,160154,380147,473153,248000000000
       Property Plant Equipment 
104,683
73,681
72,131
70,957
68,088
67,603
74,622
70,652
67,361
133,623
127,527
130,600
128,353
126,983
131,316
141,223
137,955
141,643
175,509
188,225
185,832
183,457
178,036
165,859
168,798
164,041
160,310
156,656
156,656160,310164,041168,798165,859178,036183,457185,832188,225175,509141,643137,955141,223131,316126,983128,353130,600127,527133,62367,36170,65274,62267,60368,08870,95772,13173,681104,683
       Long Term Investments 
960
960
802
746
3,654
3,654
4,072
5,215
2,909
2,681
3,447
1,788
1,734
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,7341,7883,4472,6812,9095,2154,0723,6543,654746802960960
       Intangible Assets 
2,507
2,408
2,306
2,265
1,948
17,269
17,186
16,974
1,390
16,874
16,428
21,991
24,347
24,427
33,205
38,295
42,434
44,020
47,971
50,388
53,130
52,918
54,649
58,405
60,588
61,872
57,490
56,428
56,42857,49061,87260,58858,40554,64952,91853,13050,38847,97144,02042,43438,29533,20524,42724,34721,99116,42816,8741,39016,97417,18617,2691,9482,2652,3062,4082,507
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
1,409
1,411
1
155,160
1,757
-456
573
54
0
-457
-257
-75
-74
6,729
6,907
-5
1
1,999
-1
-11,9991-56,9076,729-74-75-257-457054573-4561,757155,16011,4111,409000000000
> Total Liabilities 
105,790
101,730
80,654
100,811
147,156
136,794
155,127
86,394
101,901
178,306
180,358
186,020
175,262
170,880
203,397
217,824
195,370
205,625
244,239
267,105
275,595
289,906
300,979
234,699
262,314
277,933
293,600
307,239
307,239293,600277,933262,314234,699300,979289,906275,595267,105244,239205,625195,370217,824203,397170,880175,262186,020180,358178,306101,90186,394155,127136,794147,156100,81180,654101,730105,790
   > Total Current Liabilities 
60,152
75,032
56,796
68,848
102,813
93,898
113,453
53,012
71,514
82,791
88,635
75,858
71,753
61,365
109,276
125,164
106,179
119,578
126,974
138,203
150,933
168,918
155,852
142,799
172,223
189,714
204,473
220,045
220,045204,473189,714172,223142,799155,852168,918150,933138,203126,974119,578106,179125,164109,27661,36571,75375,85888,63582,79171,51453,012113,45393,898102,81368,84856,79675,03260,152
       Short-term Debt 
74,445
64,356
33,095
8,466
4,672
23,131
32,853
22,784
6,104
30,245
29,770
27,611
21,979
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000021,97927,61129,77030,2456,10422,78432,85323,1314,6728,46633,09564,35674,445
       Short Long Term Debt 
74,445
64,356
33,095
8,466
4,672
23,131
32,853
22,784
6,104
30,245
29,770
27,611
21,979
0
0
0
3,428
11,652
0
0
2,420
14,617
14,531
0
540
0
0
0
000540014,53114,6172,4200011,6523,42800021,97927,61129,77030,2456,10422,78432,85323,1314,6728,46633,09564,35674,445
       Accounts payable 
25,147
32,414
42,000
55,311
51,929
51,164
77,379
23,099
32,112
44,494
56,431
39,602
29,712
45,018
49,656
63,648
84,956
98,338
104,979
116,995
124,165
142,917
134,191
120,804
145,746
166,744
188,204
201,145
201,145188,204166,744145,746120,804134,191142,917124,165116,995104,97998,33884,95663,64849,65645,01829,71239,60256,43144,49432,11223,09977,37951,16451,92955,31142,00032,41425,147
       Other Current Liabilities 
6,198
4,960
5,558
5,071
13,800
19,603
3,221
7,129
6,081
8,052
2,434
8,645
2,975
11,262
9,666
11,858
10,251
9,588
10,752
9,965
12,600
11,384
-1
1
1
10,848
-1
7,280
7,280-110,84811-111,38412,6009,96510,7529,58810,25111,8589,66611,2622,9758,6452,4348,0526,0817,1293,22119,60313,8005,0715,5584,9606,198
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
95,515
91,723
110,162
103,509
109,515
94,142
92,660
89,191
86,047
117,265
128,902
124,662
120,988
145,127
92,584
90,772
88,904
89,813
87,880
87,88089,81388,90490,77292,584145,127120,988124,662128,902117,26586,04789,19192,66094,142109,515103,509110,16291,72395,515000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89,191
86,047
117,265
128,902
124,662
120,988
145,126
92,585
90,772
88,904
89,814
87,881
87,88189,81488,90490,77292,585145,126120,988124,662128,902117,26586,04789,1910000000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
81,971
0
0
0
72,302
0
0
0
112,977
0
0
0
102,815
0
0
0
000102,815000112,97700072,30200081,971000000000000
       Other Liabilities 
0
0
1
0
1
1
0
0
-1
0
-1
0
-1
-1
0
-1
-1
0
0
0
-1
0
1
-1
-1
0
-1
0
0-10-1-110-1000-1-10-1-10-10-100110100
> Total Stockholder Equity
54,221
81,973
62,665
50,637
37,748
15,580
-3,253
110,335
86,717
67,465
49,211
145,193
118,432
123,471
104,158
76,147
264,448
238,398
214,564
176,921
141,063
108,696
78,579
186,635
148,716
113,336
117,359
94,743
94,743117,359113,336148,716186,63578,579108,696141,063176,921214,564238,398264,44876,147104,158123,471118,432145,19349,21167,46586,717110,335-3,25315,58037,74850,63762,66581,97354,221
   Common Stock
233,500
233,500
233,500
233,500
233,500
233,500
233,500
294,837
294,837
294,837
294,837
324,321
325,821
329,074
3,291
3,302
3,578
3,578
3,578
3,578
3,578
3,578
3,578
3,951
3,951
3,951
3,951
3,951
3,9513,9513,9513,9513,9513,5783,5783,5783,5783,5783,5783,5783,3023,291329,074325,821324,321294,837294,837294,837294,837233,500233,500233,500233,500233,500233,500233,500
   Retained Earnings 
-179,279
-151,527
-170,835
-182,863
-195,752
-217,919
-236,753
-184,502
-208,120
-227,372
-245,626
-179,128
-208,216
-205,603
100,867
72,845
15,477
234,820
210,986
173,343
139,185
105,118
75,001
182,685
145,733
109,386
113,409
90,793
90,793113,409109,386145,733182,68575,001105,118139,185173,343210,986234,82015,47772,845100,867-205,603-208,216-179,128-245,626-227,372-208,120-184,502-236,753-217,919-195,752-182,863-170,835-151,527-179,279
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
137,485
0
0
0
0
0
0
0
0000000137,48500000000000000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
-1
0
0
0
0
0
0
827
0
0
0
8,684
1
0
0
0
0
0
-1
0
-1
113,409
-1
-1113,409-10-10000018,684000827000000-100000



Balance Sheet

Currency in NOK. All numbers in thousands.




Cash Flow

Currency in NOK. All numbers in thousands.




Income Statement

Currency in NOK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue181,058
Cost of Revenue-128,883
Gross Profit52,17552,175
 
Operating Income (+$)
Gross Profit52,175
Operating Expense-293,193
Operating Income-112,135-241,018
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense293,1930
 
Net Interest Income (+$)
Interest Income567
Interest Expense-9,956
Other Finance Cost-0
Net Interest Income-9,389
 
Pretax Income (+$)
Operating Income-112,135
Net Interest Income-9,389
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-93,013-112,135
EBIT - interestExpense = -9,956
-93,011
-83,055
Interest Expense9,956
Earnings Before Interest and Taxes (EBIT)--83,057
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-93,013
Tax Provision-0
Net Income From Continuing Ops-93,013-93,013
Net Income-93,011
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-9,389
 

Technical Analysis of Hofseth Biocare ASA
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hofseth Biocare ASA. The general trend of Hofseth Biocare ASA is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hofseth Biocare ASA's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hofseth Biocare ASA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.2 < 2.2 < 2.23.

The bearish price targets are: 2 > 2 > 2.

Tweet this
Hofseth Biocare ASA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hofseth Biocare ASA. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hofseth Biocare ASA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hofseth Biocare ASA. The current macd is -0.0329919.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hofseth Biocare ASA price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hofseth Biocare ASA. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hofseth Biocare ASA price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Hofseth Biocare ASA Daily Moving Average Convergence/Divergence (MACD) ChartHofseth Biocare ASA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hofseth Biocare ASA. The current adx is 27.59.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hofseth Biocare ASA shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Hofseth Biocare ASA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hofseth Biocare ASA. The current sar is 1.97104348.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Hofseth Biocare ASA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hofseth Biocare ASA. The current rsi is 40.22. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Hofseth Biocare ASA Daily Relative Strength Index (RSI) ChartHofseth Biocare ASA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hofseth Biocare ASA. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hofseth Biocare ASA price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Hofseth Biocare ASA Daily Stochastic Oscillator ChartHofseth Biocare ASA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hofseth Biocare ASA. The current cci is -118.41351661.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Hofseth Biocare ASA Daily Commodity Channel Index (CCI) ChartHofseth Biocare ASA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hofseth Biocare ASA. The current cmo is -27.6993196.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hofseth Biocare ASA Daily Chande Momentum Oscillator (CMO) ChartHofseth Biocare ASA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hofseth Biocare ASA. The current willr is -86.95652174.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Hofseth Biocare ASA Daily Williams %R ChartHofseth Biocare ASA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hofseth Biocare ASA.

Hofseth Biocare ASA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hofseth Biocare ASA. The current atr is 0.12525492.

Hofseth Biocare ASA Daily Average True Range (ATR) ChartHofseth Biocare ASA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hofseth Biocare ASA. The current obv is -11,437,496.

Hofseth Biocare ASA Daily On-Balance Volume (OBV) ChartHofseth Biocare ASA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hofseth Biocare ASA. The current mfi is 32.76.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Hofseth Biocare ASA Daily Money Flow Index (MFI) ChartHofseth Biocare ASA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hofseth Biocare ASA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Hofseth Biocare ASA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hofseth Biocare ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.217
Ma 20Greater thanMa 502.120
Ma 50Greater thanMa 1002.211
Ma 100Greater thanMa 2002.399
OpenGreater thanClose2.020
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hofseth Biocare ASA with someone you think should read this too:
  • Are you bullish or bearish on Hofseth Biocare ASA? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hofseth Biocare ASA? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hofseth Biocare ASA

I send you an email if I find something interesting about Hofseth Biocare ASA.


Comments

How you think about this?

Leave a comment

Stay informed about Hofseth Biocare ASA.

Receive notifications about Hofseth Biocare ASA in your mailbox!